DCGI

A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of Covaxin

The approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...

AIIMS director hails DCGI approval of 'India-made' COVID vaccine

"It is a great moment for India and for our fight against COVID-19. Bharat Biotech's Covaxin is a vaccine that has been made in India. A ma...

DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situation

The subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.

DCGI gives emergency-use approval to Covaxin, Covishield vaccines

India's drugs regulator DCGI says it has approved Oxford-Serum Institute's COVID-19 vaccine Covishield and Bharat Biotech's Covaxin for res...

Covishield gets conditional approval from Expert panel, waiting for DCGI's final approval

Massive Covid vaccine breakthrough in India: Covishield gets conditional approval. DCGI will give final approval for Covishield. Serum, whi...

Zydus Cadila receives DCGI nod for NAFLD drug Saroglitazar Mg in India

Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patient...

AstraZeneca gets DCGI nod for asthma drug

The company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml...

AstraZeneca Pharma gets DCGI nod to market asthma drug

AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt ...

Covid-19: India's first indigenous mRNA vaccine gets DCGI nod for human trial

India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II huma...

Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccine

The recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...

DCGI may await UK nod for AstraZeneca's Covid shot before approving SII vaccine

Officials said both the Pfizer and the SII emergency use applications are being reviewed on an accelerated basis. But as the trials for Ser...

Bharat Biotech seeks DCGI nod for Covaxin use

“After Pfizer and Serum Institute of India, Bharat Biotech has also applied to the drug regulator for market authorisation approval now,” s...

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...

Covid-19: Serum Institute seeks emergency authorisation for Oxford vaccine Covishield in India

The Serum Institute of India on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking...

DCGI rejects Dr Reddy's proposal seeking change in regulatory approval status for remdesivir

Dr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeki...

Bharat biotech's COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (I...

Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indication

Diabetic Macular Edema occurs when high blood sugar levels damage capillaries that leak fluid into the retina, resulting in swelling and bl...